Award
Delivery Order #SPE2D326F150H
Pfizer Delivery Order for Cyklokapron Injectable Medication
Buyer
Defense Logistics Agency
Award Amount
$179.68
Ceiling
$179.68
Awarded
May 27, 2026
Period of Performance
May 27, 2026 – May 28, 2026
Identifier
SPE2D326F150H
NAICS
325412
This is a pharmaceutical delivery order issued to Pfizer Inc., a supplier of medicines, under the parent indefinite-delivery contract for pharmaceutical products. It covers Cyklokapron (tranexamic acid), supplied as 1,000 mg in a 10 mL vial, for delivery in New York. The order supports access to injectable medication through the Defense Logistics Agency’s broader military pharmaceutical supply arrangement. The parent contract was described as competitively awarded; the data does not specify the competition method for this individual order. The delivery order has a very short performance period, running from late May 2026 through the following day. No acquisition program, subcontractors, previous delivery orders, or original solicitation details are provided.
Description
4571942326!CYKLOKAPRON 1,000 MG/10 ML VL 10ML